BiotechTube
Home/STRM.BIO/Robert Hughes
RH

Robert Hughes

Chief Financial Officer

STRM.BIO

Therapeutic Areas

Rare Hematological DiseasesOncology

STRM.BIO Pipeline

DrugIndicationPhase
MV Platform for Rare DiseaseFanconi anemiaPreclinical
MV Platform for Cell TherapyIn vivo CAR-T therapiesPreclinical

Leadership Team at STRM.BIO

ML
Michael Luther, Ph.D., MBA
Chief Executive Officer
LG
Laura Goldberg, M.D., Ph.D.
Vice President of Research
View full STRM.BIO profile